Euronext – pharmaceutical daily

February 8, 2017 Off

Lysogene raises €22.6 million, focuses on developing two drugs for deadly CNS diseases

French biotechnology company Lysogene has kicked off well with its initial public offering on Euronext Paris stock market by raising €22.6 million.

December 15, 2016 Off

TiGenix raises $35.65M proceeds with NASDAQ IPO

By Dino Mustafić

A biopharmaceutical company TiGenix focused on allogeneic expanded stem cells, has raised $35.65 million gross proceeds from the sale of 2,300,000 American Depository…

November 27, 2015 Off

No revenues for Kiadis Pharma in the first 9 months 2015

By Dino Mustafić

Kiadis Pharma did not generate any revenues in the first nine months of 2015, the company said Friday.